{Reference Type}: Journal Article
{Title}: Percutaneous Treatment of Giant Cystic Echinococcosis in Liver: Catheterization Technique in Patients with CE1 and CE3a.
{Author}: Balli O;Balli G;Cakir V;Gur S;Pekcevik R;Tavusbay C;Akhan O;
{Journal}: Cardiovasc Intervent Radiol
{Volume}: 42
{Issue}: 8
{Year}: Aug 2019
{Factor}: 2.797
{DOI}: 10.1007/s00270-019-02248-z
{Abstract}: <B>OBJECTIVE: </B>This study aimed to evaluate the efficacy, safety, and follow-up results of the percutaneous treatment of cystic echinococcosis (CE) patients with giant hepatic cysts (at least one diameter > 10 cm).<BR><B>METHODS: </B>Between January 2013 and 2018, 31 CE patients with 34 giant cysts classified as CE1 or CE3a (Gharbi type 1 or 2) according to the World Health Organization criteria and treated with the catheterization technique were analyzed retrospectively.<BR><B>RESULTS: </B>Thirty-four giant hepatic cysts were treated using the catheterization technique. Technical success was 100%. One procedure was sufficient for 27 of these cysts, while six patients underwent a second procedure due to recurrence, recollection or complications; one did not accept a repeat procedure and decided to refer to surgery due to pain. Ten (29%) major complications developed. The overall clinical success was 97%. The mean follow-up period was 20 months (5-61 months), and the total reduction in the cyst volume was 92%.<BR><B>CONCLUSIONS: </B>The catheterization technique is effective in treating giant CE with acceptable complication rates.<BR><B>METHODS: </B>Level 4, Clinical Investigation.